Sandbox lung cancer differential: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
* Pulmonary vascular changes in primary tumors are characterized by vascular infiltration, destruction and occlusion whereas in secondary tumors intravascular embolisation and extravasation predominate.
* Pulmonary vascular changes in primary tumors are characterized by vascular infiltration, destruction and occlusion whereas in secondary tumors intravascular embolisation and extravasation predominate.
{| class="wikitable"
{| class="wikitable"
! colspan="11" |Malignant lung carcnimoma
! colspan="11" |Benign Lung Tumors
|-
!
!
!
!Risk/Epidemiology
!Pleuripotent cells
!Topography
!Gross
!Histology
!Immunohistochemistry
!Imaging
!Mets
|-
| rowspan="3" |Papilloma
| colspan="2" |Squamous cell
|
* HPV 6 and 11
*
|
* Endonronchial
|
* Cauliflower-like lesions
* Tan-white soft to semifirm protrutions
|
* Loose fibrovascular core
* Stratified squamous epithelium
* Acanthosis
* Wrinkled nuclei
* Binucleate forms and perinuclear halos
* Koilocytosis
* Dyskeratotic cells
* Large atypical cells
* Occasional mitotic figure
|
* N/A
|
|
|
|-
| colspan="2" |Glandular
|
|
|
|
|
|
|
|
|-
| colspan="2" |Mixed
|
|
|
|
|
|
|
|
|-
| rowspan="4" |Adenoma
| colspan="2" |Alveolar adenoma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Papillary adenoma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Mucinous cystadenoma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Lymphoproliferative
|
|
|
|
|
|
|
|
|-
| rowspan="6" |Miscelleneous
| colspan="2" |Harmatoma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Sclerosing hemangioma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Clear cell tumor
|
|
|
|
|
|
|
|
|-
| colspan="2" |Germ cell tumors
|
|
|
|
|
|
|
|
|-
| colspan="2" |Intrapulmonary thymoma
|
|
|
|
|
|
|
|
|-
| colspan="2" |Melanoma
|
|
|
|
|
|
|
|
|-
! colspan="11" |Malignant Lung Tumors
|-
|-
! colspan="3" |Variant of lung carci
! colspan="3" |Variant of lung carci
Line 15: Line 177:
!Pleuripotent cell
!Pleuripotent cell
!Topography
!Topography
!Gross
!Histology
!Histology
!Gross
!Immunohistochemistry
!Immunohistochemistry
!Imaging
!Imaging
Line 29: Line 191:
| rowspan="4" |
| rowspan="4" |
* Central
* Central
|
* Exophytic
* Intra-epithelial 
* Without invasion
| rowspan="4" |
| rowspan="4" |
* White or grey lesions
* White or grey lesions
Line 39: Line 197:
* Intraluminal polypoid masses  
* Intraluminal polypoid masses  
* Infiltration  
* Infiltration  
|
* Exophytic
* Intra-epithelial 
* Without invasion
| rowspan="4" |
| rowspan="4" |
* Keratin  
* Keratin  
Line 73: Line 235:
* Bronchial precursor cell
* Bronchial precursor cell
|
|
|
* White-tan, soft, friable perihilar masses.
* Extensive necrosis.
* 5% peripheral coin lesions
|
|
* Sheet-like growth
* Sheet-like growth
Line 80: Line 246:
* Rosette formation
* Rosette formation
* High mitotic rate  
* High mitotic rate  
|
* White-tan, soft, friable perihilar masses.
* Extensive necrosis.
* 5% peripheral coin lesions
|
|
* CD56
* CD56
Line 104: Line 266:
| rowspan="11" |
| rowspan="11" |
* Peripheral
* Peripheral
|
| rowspan="11" |
| rowspan="11" |
* Single or multiple lesions
* Single or multiple lesions
Line 116: Line 277:
** Hemorrhage.
** Hemorrhage.
* Lobulated or ill defined edges.
* Lobulated or ill defined edges.
|
| rowspan="11" |
| rowspan="11" |
* Epithelial markers (AE1/AE3, CAM 5.2)  
* Epithelial markers (AE1/AE3, CAM 5.2)  
Line 200: Line 362:
* Peripheral masses
* Peripheral masses
* Bronchi
* Bronchi
|
*Invasive growth pattern
*Peripheral palisading
*Small, monomorphic, cuboidal fusiform
| rowspan="5" |
| rowspan="5" |
* Soft, pink-tan tumor  
* Soft, pink-tan tumor  
Line 210: Line 368:
* Cavitations.  
* Cavitations.  
* Exophytic bronchial growth  
* Exophytic bronchial growth  
|
*Invasive growth pattern
*Peripheral palisading
*Small, monomorphic, cuboidal fusiform
| rowspan="5" |
| rowspan="5" |
*[[Chromogranin]]
*[[Chromogranin]]
Line 264: Line 426:
* Central or peripheral
* Central or peripheral
* Upper lobes
* Upper lobes
|
* Biphasic
* Mixture of carcinomatous and sarcomatous cells
| rowspan="5" |
| rowspan="5" |
* > 5 cm
* > 5 cm
Line 274: Line 433:
* Sessile or pedunculated  
* Sessile or pedunculated  
* Infiltrative
* Infiltrative
|
* Biphasic
* Mixture of carcinomatous and sarcomatous cells
|
|
* Keratin  
* Keratin  
Line 326: Line 488:


* AC is more commonly peripheral
* AC is more commonly peripheral
|
* Firm, well demarcated, tan to yellow tumors.
|
|
* Uniform polygonal cells  
* Uniform polygonal cells  
Line 333: Line 497:
* Highly vascularized fibrovascular stroma
* Highly vascularized fibrovascular stroma
* Focal necrosis
* Focal necrosis
|
* Firm, well demarcated, tan to yellow tumors.
|
|
* Cytokeratin  
* Cytokeratin  
Line 360: Line 522:
|
|
* Bronchial glands
* Bronchial glands
|
* Ranging in size from 0.5-6 cm
* Soft, polypoid, and pink-tan in colour
* High-grade lesions are infiltrative
|
|
* Exophytic endobronchial growth
* Exophytic endobronchial growth
Line 365: Line 531:
* Absence of individual cell keratinization
* Absence of individual cell keratinization
* Transitional areas to low grade mucoepidermoid carcinoma.
* Transitional areas to low grade mucoepidermoid carcinoma.
|
* Ranging in size from 0.5-6 cm
* Soft, polypoid, and pink-tan in colour
* High-grade lesions are infiltrative
|
|
*  
*  
Line 390: Line 552:
|
|
* Trachea
* Trachea
|
* Invades other cell layers.
* Heterogeneous cellularity
* Cribriform pattern
* Perineural invasion
|
|
* Gray-white or tan polypoid lesions.
* Gray-white or tan polypoid lesions.
Line 401: Line 558:


* Infiltrative margins.
* Infiltrative margins.
|
* Invades other cell layers.
* Heterogeneous cellularity
* Cribriform pattern
* Perineural invasion
|
|
* Immunoperoxidase  
* Immunoperoxidase  
Line 427: Line 589:
|
|
* Endobronchia
* Endobronchia
|
* Solid to gelatinous in texture
* White to gray in colour
|
|
* Myoepithelial cells
* Myoepithelial cells
* Dual layer of cells lining ducts.
* Dual layer of cells lining ducts.
* Low mitotic activity.
* Low mitotic activity.
|
* Solid to gelatinous in texture
* White to gray in colour
|
|
* MNF116  
* MNF116  
Line 449: Line 611:
|
|
* Bronchi
* Bronchi
|
* Focal or multi-focal plaque-like greyish lesions
* Nonspecific erythema
* Even nodular or polypoid lesions
|
|
* Goblet cell hyperplasia
* Goblet cell hyperplasia
Line 459: Line 625:


* Micropapillomatosis
* Micropapillomatosis
|
* Focal or multi-focal plaque-like greyish lesions
* Nonspecific erythema
* Even nodular or polypoid lesions
|
|
* EGFR  
* EGFR  
Line 485: Line 647:
* Pleura  
* Pleura  
* Upper lobes
* Upper lobes
|
* Multiple grey to yellow foci
* 1mm to 10mm in size.
|
|
* Intranuclear inclusions
* Intranuclear inclusions
Line 492: Line 657:
* Moderate atypia.
* Moderate atypia.
* Pseudopapillae
* Pseudopapillae
|
* Multiple grey to yellow foci
* 1mm to 10mm in size.
|
|
* CEA  
* CEA  
Line 518: Line 680:
|
|
* Endobronchial
* Endobronchial
|
* Nodular aggregates
* Fibrosis due to proliferation
* Invade locally
* Fibrous stroma aggregates to form ‘tumorlets’.
* Carcinoids are tumorlets >5cm.
|
|
* Early lesions
* Early lesions
Line 533: Line 689:
** Well-defined
** Well-defined
** Grey or yellow-white masses.  
** Grey or yellow-white masses.  
|
* Nodular aggregates
* Fibrosis due to proliferation
* Invade locally
* Fibrous stroma aggregates to form ‘tumorlets’.
* Carcinoids are tumorlets >5cm.
|
|
|
|
Line 549: Line 711:
|
|
* Intravascular
* Intravascular
|
* 0.3-2.0 cm circumscribed mass
* Gray-white or gray-tan firm tissue
* Yellow flecks
* Central calcifications
* Cut surface has a cartilaginous consistency. 
|
|
* Round to oval-shaped nodules
* Round to oval-shaped nodules
Line 556: Line 724:
** Calcifications
** Calcifications
** Intranuclear cytoplasmic inclusions
** Intranuclear cytoplasmic inclusions
|
* 0.3-2.0 cm circumscribed mass
* Gray-white or gray-tan firm tissue
* Yellow flecks
* Central calcifications
* Cut surface has a cartilaginous consistency. 
|
|
* CD31
* CD31
Line 590: Line 752:
* Pleura  
* Pleura  
* Lung
* Lung
|
* Purely cystic
* Thin-walled
* Rarely solid
* Firm to gelatinous
* Upto 15 cm
|
|
* Type I
* Type I
Line 599: Line 767:
* Type III
* Type III
** Mixed cells
** Mixed cells
|
* Purely cystic
* Thin-walled
* Rarely solid
* Firm to gelatinous
* Upto 15 cm
|
|
* Vimentin
* Vimentin
Line 631: Line 793:
** Bone
** Bone
** Paraganglia
** Paraganglia
|
* Peripheral
* Solid lesions
* Calcified
|
|
* Capsulated lobules  
* Capsulated lobules  
* Hypocellular
* Hypocellular
* Features of malignancy are absent
* Features of malignancy are absent
|
* Peripheral
* Solid lesions
* Calcified
|
|
* N/A
* N/A
Line 658: Line 820:
* Spindle cells
* Spindle cells
|
|
|
* Fascicles of spindle cells.
* Bronchial invasion
* Peribronchial distribution
* Cystic foci of haemorrhage
|
|
* 5-10 cm  
* 5-10 cm  
Line 671: Line 828:
** Haemorrhage  
** Haemorrhage  
** Necrosis
** Necrosis
|
* Fascicles of spindle cells.
* Bronchial invasion
* Peribronchial distribution
* Cystic foci of haemorrhage
|
|
* Vimentin
* Vimentin
Line 687: Line 849:
|
|
* Along the lymphatic distribution.
* Along the lymphatic distribution.
|
* Prominence of the bronchovascular bundles along
** Pleura
** Interlobular pulmonary septa
** Mediastinum
|
|
* Anastomosing endothelial-lined cells along lymphatic routes.
* Anastomosing endothelial-lined cells along lymphatic routes.
Line 692: Line 859:
* Spindle cells
* Spindle cells
* Intra alveolar siderophages
* Intra alveolar siderophages
|
* Prominence of the bronchovascular bundles along
** Pleura
** Interlobular pulmonary septa
** Mediastinum
|
|
* FVIIIrAg  
* FVIIIrAg  
Line 720: Line 882:
|
|
* Localized to bronchia
* Localized to bronchia
|
* Mixture of spindle cells
** Fibroblastic
** Myofibroblastic
* Arranged in fascicles
* Cytologic atypia
* Touton type giant cells.
* Plasma cells
* Lymphoid follicles
|
|
* Solitary
* Solitary
Line 739: Line 892:
* Calcifications  
* Calcifications  
* No local invasion
* No local invasion
|
* Mixture of spindle cells
** Fibroblastic
** Myofibroblastic
* Arranged in fascicles
* Cytologic atypia
* Touton type giant cells.
* Plasma cells
* Lymphoid follicles
|
|
* Vimentin  
* Vimentin  
Line 767: Line 929:
** Pulmonary valve,
** Pulmonary valve,
** Right ventricular outflow tract
** Right ventricular outflow tract
|
* Spindle cells in
** A myxoid background
** Collagenized stroma
** Recanalized thrombi
|
|
* Mucoid or gelatinous clots filling vascular lumens
* Mucoid or gelatinous clots filling vascular lumens
Line 778: Line 935:
** Bony/gritty or chondromyxoid foci
** Bony/gritty or chondromyxoid foci
** Haemorrhage and necrosis are common in high-grade tumors
** Haemorrhage and necrosis are common in high-grade tumors
|
* Spindle cells in
** A myxoid background
** Collagenized stroma
** Recanalized thrombi
|
|
* Vimentin
* Vimentin
Line 801: Line 963:
|
|
* Pulmonary vein
* Pulmonary vein
|
* Smooth muscle differentiation
* Moderate to highly cellular spindle cell neoplasms
* Epithelioid morphology
|
|
* Fleshy-tan tumor
* Fleshy-tan tumor
Line 810: Line 968:
* 3.0- 20.0 cm
* 3.0- 20.0 cm
* Invasion of wall of the vein.
* Invasion of wall of the vein.
|
* Smooth muscle differentiation
* Moderate to highly cellular spindle cell neoplasms
* Epithelioid morphology
|
|
* Vimentin
* Vimentin

Revision as of 16:11, 9 March 2018

  • Differentiation of primary and secondary lun tumors is difficult due to overlapping histologic features.
  • Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.
  • Primary lung tumors are mainly localized in upper lobes as singular nodules, metastases in lower lobes as multiple lesions.
  • On the contarary, endobronchial primary or secondary squamous cell carcinomas findings of severe dysplasia and CIS of the bronchial epithelium are important.
  • Stroma and vascularisation pattern of primary and secondary lung tumors differ in distribution, arrangement and extracellular matrix components.
  • Pulmonary vascular changes in primary tumors are characterized by vascular infiltration, destruction and occlusion whereas in secondary tumors intravascular embolisation and extravasation predominate.
Benign Lung Tumors
Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Mets
Papilloma Squamous cell
  • HPV 6 and 11
  • Endonronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Wrinkled nuclei
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • Dyskeratotic cells
  • Large atypical cells
  • Occasional mitotic figure
  • N/A
Glandular
Mixed
Adenoma Alveolar adenoma
Papillary adenoma
Mucinous cystadenoma
Lymphoproliferative
Miscelleneous Harmatoma
Sclerosing hemangioma
Clear cell tumor
Germ cell tumors
Intrapulmonary thymoma
Melanoma
Malignant Lung Tumors
Variant of lung carci

mao

Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Mets
Squamous cell carcinoma Papillary
  • Cigarette smokers
  • Arsenic
  • Central
  • White or grey lesions
  • Focal carbon pigment deposits
  • Cavitations.
  • Intraluminal polypoid masses
  • Infiltration
  • Exophytic
  • Intra-epithelial
  • Without invasion
  • Keratin
  • Cytokeratins
  • CEA
  • Thyroid transcription factor-1 (TTF-1)
  • Lobar or entire lung collapse
  • Shift of the mediastinum to the ipsilateral side.
  • Hilar, perihilar or mediastinal masses
Clear cell
  • Cells with clear cytoplasm
Small cell
  • Poorly differentiated cells
  • Focal squamous
  • No characteristic nuclear features of SCC.
  • Intercellular bridges or keratinization.
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma
  • Smoking
  • Radon exposure
  • Bronchial precursor cell
  • White-tan, soft, friable perihilar masses.
  • Extensive necrosis.
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting,
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • CD56
  • Chromogranin
  • Synaptophysin
  • TTF-1
  • Hilar or perihilar masses
  • Mediastinal lymphadenopathy
  • Lobar collapse
  • Bone marrow
  • Liver metastases
Adeno carcinoma Adenocarcinoma, mixed sub type
  • Smokers
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution.
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation.
    • Necrosis,
    • Cavitation
    • Hemorrhage.
  • Lobulated or ill defined edges.
  • Epithelial markers (AE1/AE3, CAM 5.2)
  • Carcinoembryonic antigen
  • CK7
  • TTF-1
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
Acinar adenocarcinoma
Papillary adenocarcinoma
  • Papillae
  • Necrosis
  • Surrounding invasion
  • Cuboidal to columnar epithemlial linning
  • Mucinous or non-mucinous
Bronchio-alveolar carcinoma Non-mucinous
  • Clara cells
  • Type II cells
Mucinous
  • Low grade differentiation
  • Composed of
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
  • Consists glandular elements
    • Tubules of glycogen-rich
    • Non-ciliated cells
    • Subnuclear and supranuclear glycogen vacuoles
    • Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
Mucinous (“colloid”) carcinoma
  • Dissecting pools of mucin containing neoplastic cells.
Mucinous cystadenocarcinoma
  • Partial fibrous tissue capsule.
  • Central cystic change with mucin pooling
  • Neoplastic mucinous epithelium grows along alveolar walls.
Signet ring adenocarcinoma
Clear cell adenocarcinoma
Large cell carcinoma Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers.
  • Smoking
  • Neuro endocrine cells
  • Suprabasal bronchial cells.
  • Peripheral masses
  • Bronchi
  • Soft, pink-tan tumor
  • Necrosis and occasional hemorrhage
  • Cavitations.
  • Exophytic bronchial growth
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
  • Pleura
  • Liver
  • Bone
  • Brain
  • Abdominal lymph nodes
  • Pericardium
Clear cell carcinoma of the lung
  • Clear cells
Lymphoepithelioma-like carcinoma of the lung
  • Syncytial growth pattern
  • Eosinophilic nucleoli
  • Lymphocytic infiltration
  • Invasive
  • amyloid deposition
Large-cell lung carcinoma with rhabdoid phenotype
  • Eosinophilic cytoplasmic globules
  • Small foci of adenocarcinoma
  • Eosinophilic inclusions
Mixed type
Sarcomatoid carcinoma Carcinosarcoma
  • Accounts for only 0.3-1.3% of all lung malignancies
  • Mean age at diagnosis is 60 years
  • Tobacco smoking
  • Asbestos exposure
  • Undifferentiated epithelial cells
  • Central or peripheral
  • Upper lobes
  • > 5 cm
  • Well circumscribed
  • Grey, yellow or tan creamy, gritty,
  • Mucoid and/or hemorrhagic with significant necrosis.
  • Sessile or pedunculated
  • Infiltrative
  • Biphasic
  • Mixture of carcinomatous and sarcomatous cells
  • Keratin
  • S-100
  • No specific imaging features 
  • Aggressive tumor
  • Esophagus, jejunum, rectum
  • Kidney
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
  • Keratin
  • EMA
  • Cytokeratin
  • Vimentin,
  • CEA
  • TTF-1
Giant cell carcinoma
  • Multi- and/or mononucleated tumor giant cells
Pleomorphic carcinoma
  • Poorly differentiated
  • Mixture of spindle cells and/or giant cells
  • Fibrous or myxoid stroma
Pulmonary blastoma
  • Biphasic
  • Mixture of epithelial and mesenchymal stroma
  • Keratin
  • EMA
  • CEA
  • Chromogranin A
Carcinoid tumour Typical carcinoid

Atypical carcinoid

  • Neuroendocrine cells of lung
  • Typical carcinoids are throughout the lungs
  • AC is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors.
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
  • Cytokeratin
  • Chromogranin
  • Synaptophysin
  • Leu-7 (CD57)
  • N-CAM (CD56)
  • S-100 protein
  • Well defined pulmonary nodules
  • Calcifications is often seen.
  • Intense contrast enhancement.
  • Liver
  • Bone
Salivary gland tumours Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors.
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Exophytic endobronchial growth
  • Surface epithelium lacking changes of insitu carcinoma
  • Absence of individual cell keratinization
  • Transitional areas to low grade mucoepidermoid carcinoma.
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
  • Rare
  • Liver
  • Bones
  • Adrenal gland
  • Brain
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors.
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Trachea
  • Gray-white or tan polypoid lesions.
  • Size ranges from 1–4 cm
  • Infiltrative margins.
  • Invades other cell layers.
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Immunoperoxidase
  • Cytokeratin
  • Vimentin
  • Actin
  • Calponin
  • S-100 protein
  • p63
  • GFAP
  • Liver
  • Brain
  • Bone
  • Spleen
  • Kidney
  • Adrenal glands
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association between smoking
  • Myoepithelial cells
  • Endobronchia
  • Solid to gelatinous in texture
  • White to gray in colour
  • Myoepithelial cells
  • Dual layer of cells lining ducts.
  • Low mitotic activity.
  • MNF116
  • EMA
  • SMA and S-100
  • Reflects airway obstruction
Preinvasive lesions Squamous carcinoma in situ
  • Basal cells of squamous epithelium
  • Bronchi
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Goblet cell hyperplasia
  • Basal cell hyperplasia
  • Squamous dysplasia
  • Angiogenic squamous dysplasia
  • Micropapillomatosis
  • EGFR
  • HER2/neu
  • p53
  • MCM2
  • Ki-67
  • Cytokeratin 5/6
  • bcl-2
  • VEGF
  • Folate binding protein
  • p16
Atypical adenomatous hyperplasia
  • Surfactant apoprotein
  • Clara cell specific 10kDd protein
  • Pleura
  • Upper lobes
  • Multiple grey to yellow foci
  • 1mm to 10mm in size.
  • Intranuclear inclusions
  • Clara cells and type II pneumocytes.
  • Thickened alveolar walls
  • Discontinuous lining of cells
  • Moderate atypia.
  • Pseudopapillae
  • CEA
  • MMPs
  • E-cadherin,
  • ß-catenin,
  • CD44v6
  • TTF-1
  • TP53
  • Typically not visualized on radiographs.
  • Small non-solid nodules
  • Ground glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Pulmonary neuroendocrine cells
  • Endobronchial
  • Early lesions
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumours are
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses.
  • Nodular aggregates
  • Fibrosis due to proliferation
  • Invade locally
  • Fibrous stroma aggregates to form ‘tumorlets’.
  • Carcinoids are tumorlets >5cm.
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Mesenchymal tumors Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women.
  • Endothelial cells
  • Intravascular
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency.
  • Round to oval-shaped nodules
    • Central sclerosis
    • Hypocellular zone
    • Peripheral cellular zone
    • Calcifications
    • Intranuclear cytoplasmic inclusions
  • CD31
  • CD34
  • factor VIII (von Willebrand factor)
  • Fli1
  • FKBP12
  • Cytokeratin
  • Multiple
  • Bilateral
  • Small nodules
  • 1-2 cm in size.
  • Can mimic pulmonary Langerhans’ cell histiocytosis.
  • Calcifications
  • Liver
  • Bone
  • Soft tissue
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years.
  • Thoracic splanchnopleural mesenchyme.
  • Pleura
  • Lung
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Type I
    • Purely cystic
    • Lined by respiratory type epithelium
    • Underneath malignant cells
  • Type II
    • Partial or complete overgrowth of the septal stroma
  • Type III
    • Mixed cells
  • Vimentin
  • S-100 protein
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
  • Brain
  • Spinal cord
  • Skeletal system
  • Eyes
  • Pancreas
Chondroma
  • Young women
  • Chondrocytes,
  • Cartilaginous cells
  • Peripheral lesions in lung
  • 1o seen in
    • Stomach
    • Bone
    • Paraganglia
  • Peripheral
  • Solid lesions
  • Calcified
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
  • Benign tumor
Congenital peribronchial myofibroblastic tumor
  • Rare
  • Sporadic
  • Complicated by
    • Polydramnios
    • Non-immune hydrops fetalis
  • Spindle cells
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance.
    • Haemorrhage
    • Necrosis
  • Fascicles of spindle cells.
  • Bronchial invasion
  • Peribronchial distribution
  • Cystic foci of haemorrhage
  • Vimentin
  • Well circumscribed
  • Opacifying the hemithorax
  • Heterogeneous mass
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Smooth muscles cells of lymphatic vessels.
  • Along the lymphatic distribution.
  • Prominence of the bronchovascular bundles along
    • Pleura
    • Interlobular pulmonary septa
    • Mediastinum
  • Anastomosing endothelial-lined cells along lymphatic routes.
  • Spindle cells
  • Intra alveolar siderophages
  • FVIIIrAg
  • Vimentin
  • UEA
  • Increased interstitial markings
  • Thickening of the
    • Interlobular septa
    • Fissures
    • Central airways
    • Pleura
Inflammatory myofibroblastic tumor
  • Previous viral infections
  • HHV8
  • Children
  • Myofibroblastic cells
  • Localized to bronchia
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non encapculated
  • Calcifications
  • No local invasion
  • Mixture of spindle cells
    • Fibroblastic
    • Myofibroblastic
  • Arranged in fascicles
  • Cytologic atypia
  • Touton type giant cells.
  • Plasma cells
  • Lymphoid follicles
  • Vimentin
  • Actin
  • ALK1
  • p80
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
    • Post-obstructive pneumonia
    • Atelectasis
  • Rare
Pulmonary artery sarcoma
  • Mean age of diagnosis is 49.3 years
  • Commonly misdiagnosed as PE
  • Mesenchymal cells of the intima
  • Primitive cells of the bulbus cordi in the trunk of pulmonary artery.
  • Pulmonary trunk most commonly
    • Right pulmonary artery
    • Left pulmonary artery
    • Pulmonary valve,
    • Right ventricular outflow tract
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Haemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
  • Vimentin
  • Osteopontin
  • Factor VIII
  • CD31
  • CD34
  • Findings overlap with those of chronic thromboembolic disease
  • Decreased vascularity
  • Heterogeneous soft tissue density
  • Smooth vascular tapering
  • Lung
  • Mediastinum
Pulmonary vein sarcoma
  • Most common in women.
  • Mean age of diagnosis is 49.
  • Smooth muscle
  • Pulmonary vein
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel.
  • 3.0- 20.0 cm
  • Invasion of wall of the vein.
  • Smooth muscle differentiation
  • Moderate to highly cellular spindle cell neoplasms
  • Epithelioid morphology
  • Vimentin
  • Desmin and actin
  • Keratin
  • N/A
Benign lung tumor
Risk factors Gross pathology Histopathology Immunohistochemistry Topography Prognosis
Papilloma Squamous cell papilloma Exophytic and Inverted
  • HPV 6 and 11
  • Cauliflower-like tan-white soft to semifirm excrescences protruding into bronchial lumens
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Wrinkled nuclei
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • Dyskeratotic cells
  • Large atypical cells
  • Occasional mitotic figures
N/A
  • Endobronchial
  • Condylomatous papillomas have malignant potential
  • Papillomatosis may be lethal due to obstructive complications
Glandular papilloma Not specific
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • Central lesions: Noninflamed thick arborizing stromal stalks
  • Thin-walled blood vessels
  • Necrosis is absent
  • Epithelium may be nonciliated or ciliated, cuboidal or columnar or a mixture
  • Clear cytoplasm
  • Nuclei lack atypia and mitoses
N/A
  • Endobronchial
  • Benign tumours that may recur following incomplete resection
  • No malignant transformation
Mixed squamous cell and glandular papilloma
  • Tan to red, polypoid and measure from 0.2-2.5 cm
  • Fibrovascular cores
  • Scattered lymphoplasmacytic infiltrates
  • Pseudostratified ciliated and nonciliated cuboidal to columnar cells
  • Squamous atypia ranging from mild to severe dysplasia
N/A
  • Endobronchial
  • Complete resection appears to be curative
Adenomas Alveolar adenoma
Papillary adenoma
Adenomas of the salivary gland type Mucous gland adenoma
Pleomorphic adenoma
Mucinous cystadenoma
Lymphoproliferative tumors Marginal zone B-cell lymphoma of the MALT type
Diffuse large B-cell lymphoma
Lymphomatoid granulomatosis
Langerhans cell histiocytosis
Miscellaneous tumors Harmatoma
Sclerosing hemangioma
Clear cell tumor
Germ cell tumors Mature tratoma
Immature teratoma
Other germ cell tumours
Intrapulmonary thymoma
Melanoma
Metastatic tumors